These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 16377439)
1. Synthesis, conformational and pharmacological studies of glycosylated chimeric peptides of Met-enkephalin and FMRFa. Masand G; Hanif K; Sen S; Ahsan A; Maiti S; Pasha S Brain Res Bull; 2006 Jan; 68(5):329-34. PubMed ID: 16377439 [TBL] [Abstract][Full Text] [Related]
2. Chimeric peptide of met-enkephalin and FMRFa: effect of chlorination on conformation and analgesia. Hanif K; Gupta K; Gupta S; Gupta YK; Maiti S; Pasha S Neurosci Lett; 2006 Jul; 403(1-2):131-5. PubMed ID: 16764989 [TBL] [Abstract][Full Text] [Related]
3. Rationally designed chimeric peptide of met-enkephalin and FMRFa-[D-Ala2,p-Cl-Phe4]YFa induce multiple opioid receptors mediated antinociception and up-regulate their expression. Vats ID; Chaudhary S; Sharma A; Nath M; Pasha S Eur J Pharmacol; 2010 Jul; 638(1-3):54-60. PubMed ID: 20385120 [TBL] [Abstract][Full Text] [Related]
4. Effect of chronic intra-peritoneally administered chimeric peptide of met-enkephalin and FMRFa-[D-Ala2]YFa-on antinociception and opioid receptor regulation. Vats ID; Snehlata ; Nath M; Pasha MA; Pasha S Eur J Pain; 2010 Mar; 14(3):295.e1-9. PubMed ID: 19560378 [TBL] [Abstract][Full Text] [Related]
5. Hypotensive effect of novel chimeric peptides of met-enkephalin and FMRFa. Hanif K; Fahim M; Pavar MC; Bansal V; Pasha S Regul Pept; 2005 Feb; 125(1-3):155-61. PubMed ID: 15582727 [TBL] [Abstract][Full Text] [Related]
6. Lack of tolerance and morphine-induced cross-tolerance to the analgesia of chimeric peptide of Met-enkephalin and FMRFa. Gupta K; Vats ID; Gupta YK; Saleem K; Pasha S Peptides; 2008 Dec; 29(12):2266-75. PubMed ID: 18930087 [TBL] [Abstract][Full Text] [Related]
7. YFa, a chimeric opioid peptide, induces kappa-specific antinociception with no tolerance development during 6 days of chronic treatment. Vats ID; Dolt KS; Kumar K; Karar J; Nath M; Mohan A; Pasha MA; Pasha S J Neurosci Res; 2008 May; 86(7):1599-607. PubMed ID: 18183621 [TBL] [Abstract][Full Text] [Related]
8. Chimeric peptide of Met-enkephalin and FMRFa induces antinociception and attenuates development of tolerance to morphine antinociception. Gupta S; Pasha S; Gupta YK; Bhardwaj DK Peptides; 1999; 20(4):471-8. PubMed ID: 10458517 [TBL] [Abstract][Full Text] [Related]
9. Effects of intracerebroventricularly administered chimeric peptide of metenkephalin and FMRFa--[D-Ala2]YFa-on antinociception and its modulation in mice. Gupta S; Pasha S; Gupta YK; Bhardwaj DK Brain Res Bull; 2001 May; 55(1):51-7. PubMed ID: 11427337 [TBL] [Abstract][Full Text] [Related]
10. Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylation. Egleton RD; Mitchell SA; Huber JD; Palian MM; Polt R; Davis TP J Pharmacol Exp Ther; 2001 Dec; 299(3):967-72. PubMed ID: 11714884 [TBL] [Abstract][Full Text] [Related]
11. Various drug delivery approaches to the central nervous system. Pasha S; Gupta K Expert Opin Drug Deliv; 2010 Jan; 7(1):113-35. PubMed ID: 20017662 [TBL] [Abstract][Full Text] [Related]
20. Opiate-like peptides. Part V. Aminoalkylamides of Met-enkephalin and [D-Ala]2-Met-enkephalin: synthesis and analgesic activity. Rolka K; Baran L; Przegaliński E; Kupryszewski G Pol J Pharmacol Pharm; 1984; 36(6):603-10. PubMed ID: 6535153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]